Dostinex Alternatives Compared
| Dostinex | Cabergoline | Bromocriptine |
|
|---|
| Dostinex (cabergoline) | Cabergoline | Bromocriptine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hyperprolactinemia. Dostinex may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperprolactinemia. cabergoline may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Parkinson's Disease, Hyperprolactinemia, Acromegaly, Tardive Dyskinesia, Diabetes - Type 2. bromocriptine may also be used for purposes not listed in this medication guide. |
Related suggestions Hyperprolactinemia
|
|||||||||||||||
| More about Dostinex (cabergoline) | More about Cabergoline | More about Bromocriptine | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Dostinex has an average rating of 8.4 out of 10 from a total of 18 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 0% reported a negative effect. |
Cabergoline has an average rating of 7.7 out of 10 from a total of 113 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 6% reported a negative effect. |
Bromocriptine has an average rating of 5.4 out of 10 from a total of 39 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 46% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: Dostinex side effects in more detail. |
See also: cabergoline side effects in more detail. |
See also: bromocriptine side effects in more detail. |
||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all cabergoline prices |
View all bromocriptine prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Cycloset, Parlodel | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
100 hours |
100 hours |
8 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 155 drugs are known to interact with Dostinex:
|
A total of 155 drugs are known to interact with cabergoline:
|
A total of 451 drugs are known to interact with bromocriptine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
December 23, 1996 |
December 23, 1996 |
June 28, 1978 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.